Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I have always been sincere. You think I’m here to distract but everything I have said has stood to be true.
Like I said years ago, you continuously accusing me of things that I am not is the sole reason I stayed so that I can watch you get zeroed out on this.
So you can pretend that you had no vitriol towards me or not, but you slandering me and throwing false accusations at me based on nothing other than the fact that you didn’t like what I posted was simply to discredit everything I posted. Yes and that is after repeatedly telling you that everything you were saying about me is false and slander and you know better because you are well aware that I’m not.
Remember you found out the kind of money I bring down and you asked me to invest in your retirement home startup? Ya I certainly wasn’t fake then was I? lol such a joke
Every one of us has biases and that's a problem when it comes to objectivity. What we do in order to counter those innate or conditioned biases is a different story. The FACT that you can continue to defend the indefensible viz Bal and the company's contempt and disregard for their constituents is incomprehensible UNLESS you suffer from some sort of condition (which I firmly believe you do) OR you're in cahoots with the company's leadership. There is absolutely NO excuse for leadership to continue as they have been. NONE! For one, such as yourself to continue to be in denial or whatever, shows there is a problem on your end. I've already stated what I believe your issues are. To go on and on as to the possibilities and probabilities of Sint's products and/ connections is a COMPLETE WASTE AS LONG AS NOTHING CHANGES WITH THE COMPANY'S WAY OF DOING BUSINESS (if one can even call it 'business'). I WAS here when the joke with O2 blew up. I WAS here when Bal announced they were good with finances and didn't need to go to the well. And I'm here AGAIN when the dopes can't even correctly put out a recent filing with the right date and day. Like I said in 2016 concerning Ashton and his ilk, there's a reason these jokers pick THESE types of companies.
My agenda has always been clear, and that is a public company has a responsibility towards its shareholders. I haven't deviated from that central theme since I've been on Ihub (Including my time on the Sint forum). Like madg and others, you have continued throughout to accuse me of being part of the problem, whether by using various aliases, disinfo tactics, a conspiracy-driven agenda to bring the company down....whatever...doesn't matter. The FACT that you ALONE now defend this company and its ways, especially management's, shows everyone all they need to know (you have a serious problem or you're a company plant). There's really nothing left to say to you. However, I WILL on occasion as I see fit, explain to those who may be new, that this isn't and has never been a sound investment (regardless of products, connections between companies etc), based solely on the antics of leadership. Enjoy your life.....
Theres no doubt i walked right into that with my sincerity, but what does that say about you and your agenda that you resorted to exploiting it? Again you're attacking the messenger instead of the message. Have to convey the messenger is crazy since you cant dispute the facts contained within that message? Regardless, that doesnt change the fact that what the author of that post said continues to be true and has been validated by both Zimmer Biomets and Sintx actions.
Since society is made of narrative and power ultimately rests in the hands of those who are able to control those narratives, it makes no sense to fixate on individuals and it makes perfect sense to focus on narrative. What narratives are being pushed by those in power? How are those narratives being disrupted, undermined and debunked by things that are being said by dissident voices? This is the most effective lens through which to view the battle against the unelected power establishment which is crushing us all to death, not some childish fixation on who should or shouldn’t be our hero.
AnonymousMay 24, 2011 at 3:42 PM
Zimmer is looking at purchasing Amedica flat out for their techology to bolster sales in spine through licensing and to purchase the next generation of hip and knee implants. You heard it here on TSB.
AnonymousMay 24, 2011 at 3:42 PM
Zimmer is looking at purchasing Amedica flat out for their techology to bolster sales in spine through licensing and to purchase the next generation of hip and knee implants. You heard it here on TSB.
Mr Bond, they have a saying in Chicago: 'Once is happenstance. Twice is coincidence. The third time it's enemy action'.
One is an incident, two is a coincidence, three's a pattern, and four is enough for a warrant
I think he's seriously delusional but has no idea he is, and therefore believes his 'sincerity' covers it all. You may want to see this from Wikipedia. It clearly fits him, especially the "greater good" idea of his 'special' calling. Anyway, I came away from it having more compassion for the guy. Hope it sticks, as I've wasted enough time attempting to reason with him. I'm being 100% sincere but he'll see this as a personal attack or one of the 18 disinfo tactics, not recognizing his whole persona comes across like a volcanic disinfo factory. Really sad.
https://en.wikipedia.org/wiki/Grandiose_delusions
lol - this lunatic could talk the paint off the wall and/or bore it to death.....
Accusing someone of being false is not vitriol. If your role all these years was to distract from what this quote represents and keep people away to help Sintx stock continue to be manipulated, you've been here under false pretenses whether paid to do so in any form or not. Yes you can use truth to do that but that truth only represented a partial truth. Youve always downplayed Sintx connections to Zimmer and Sintx IPs worth.
AnonymousMay 24, 2011 at 3:42 PM
Zimmer is looking at purchasing Amedica flat out for their techology to bolster sales in spine through licensing and to purchase the next generation of hip and knee implants. You heard it here on TSB.
Mr Bond, they have a saying in Chicago: 'Once is happenstance. Twice is coincidence. The third time it's enemy action'.
One is an incident, two is a coincidence, three's a pattern, and four is enough for a warrant
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
It is remarkable how much was prophesied back then as an absolute certainty. Now there is just one who has a personality of never admitting fault or wrongdoing that digs their heels in further day by day. Never seen anything like it
“Madg the source of vitriol came from CL101 who was an example of an attempt to hijack the bullish narative”
HAHAHAHAHA dude you are so full of sht it’s absolutely incredible. Ya cl101 was the only source of vitriol it definitely wasn’t you accusing me of being paid every single day to try and discredit anything I said. Fck off
I wasn't a frequent poster by any means and was surprised myself I went back that far. I still have no idea how this one got on my radar. The thing that I'll always remember is that my first impression of Boston was quite a positive one. My, how things can change over time.....🤔
I should have added that another question to ask yourself when examining that quote is whether or not Sintx Si3n4 is actually considered to be part of a new generation of materials for Hip/Knee markets. According to a recent third party study published last year, seemingly unconnected to any party mentioned, it is. Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies So I think, the underlying concern that we had with our portfolio was we haven't innovated since the acquisition of LDR, and we needed to continue to innovate the portfolio specifically to Mobi-C. So there's a couple of things we're doing there. ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced it has entered into a definitive agreement to sell its spine business to H.I.G. Capital, a leading global alternative investment firm.
The fact that they are not aware that Amedica and Sintx is the same company is our first clue the authors have no association with any party connected to Sintx.
Furthermore, another question to ask, is if large companies opt to look for complimentary businesses tech to acquire rather than investing inhouse in their own tech. This is a strategy Johnson & Johnson employs so why wouldnt Zimmer Biomet? It would certainly explain why Zimmer Biomet stopped investing inhouse in spine.
Theres confirmation Zimmer Biomet stopped inhouse innovation after its LDR acquisition and that ZimVie dumped those spinal assets Zimmer Biomet divested.
However here is a quote showing J&J employs a strategy of finding external companies for acquisition over developing in-house tech.
In Figure 1, you can see J&J makes most of its money from pharmaceuticals and medical devices. They have grown these two sectors over the past decade through major capital investments in acquisitions and people development. Instead of investing in developing technology in-house, they use their size to acquire smaller companies who they believe have a promising trajectory in the healthcare space.
These are risk-averse companies that look to smaller companies like us to develop an idea, uh, and, uh, de-risk it, so to speak, and then buy that technology.
Mr Bond, they have a saying in Chicago: 'Once is happenstance. Twice is coincidence. The third time it's enemy action'.
lol for whatever reason I don’t remember you posting back then but I’m assuming you weren’t a frequent poster.
But you are quite familiar with the idiocy that was on display here then. It’s hilarious to see the old posts and the vitriol from the bulls at the time.
Actually, my first problem is responding to an individual who selectively chooses what he deems is factual in order to pursue his own narrative and agenda, while continuing to show a complete lack of objectivity in his postings. IF you read my three postings before then (in a one year's span from mid 2016 to mid 2017), along with a madg's recent ("Oh they increased revenue for one year after imploding revenue from $24mm to $500k and now they should be valued based on what? Sonny’s sht track record like yours? Went mum on weigao with zero *** update..."), you'll see people like us have been right ......for years!
But what do you do instead? Like usual, you pick what you feel like, dismissing and ignoring everything contrary to your predisposed views, while closed-mindedly labeling virtually all else as a personal attack or misinfo. Downright pathetic.
Enjoy this most accurate post from anonymous in 2011....LOL! And don't forget to buy some shares after the split. You'll probably need to build back up your share count to 100, in order to secure future voting rights.
Zimmer is looking at purchasing Amedica flat out
Your first problem is your fixating on the poster rather than the content of their post. As much as you claim the disinformation moniker shouldn't apply to your posts, your posts say otherwise.
AnonymousMay 24, 2011 at 3:42 PM
Zimmer is looking at purchasing Amedica flat out for their techology to bolster sales in spine through licensing and to purchase the next generation of hip and knee implants. You heard it here on TSB.
These are risk-averse companies that look to smaller companies like us to develop an idea, uh, and, uh, de-risk it, so to speak, and then buy that technology.
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Mr Bond, they have a saying in Chicago: 'Once is happenstance. Twice is coincidence. The third time it's enemy action'.
One is an incident, two is a coincidence, three's a pattern, and four is enough for a warrant
Interesting that you quote sources calling themselves "anonymous" as if they're automatically credible even WHEN 13 years later, buyout claims by them, STILL haven't occurred and yet sources RIGHT HERE on IHUB with their same monikers, stating things 7 and 8 years ago THAT HAVE PROVEN to be true after all, are labeled disinfo tactics or conspiracy theories set out to take the mother of all companies down.
LOL, pal you take the cake!
AnonymousMay 24, 2011 at 3:42 PM
Zimmer is looking at purchasing Amedica flat out for their techology to bolster sales in spine through licensing and to purchase the next generation of hip and knee implants. You heard it here on TSB.
wound care, oral care, health care IT, and biopharma filtration.
Mr Bond, they have a saying in Chicago: 'Once is happenstance. Twice is coincidence. The third time it's enemy action'.
One is an incident, two is a coincidence, three's a pattern, and four is enough for a warrant
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Ah, why not....
One last one for memory's sake lol...
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=134130641
Tuting my own horn....
I forget some of my early fun on this one. Even Atlanta chastened me back then, telling me it's not a scam. Much has changed since them early days; Sintx has not.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=128066667
Going down memory lane......
I believe my first post on Sintx. And here we are almost 8 yrs later....same ol' same ol'
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=124607005
Oh I see you’re still choosing to be an idiot. Nice
Man you have no idea the amount of delusion that was on display on this board at that time. It was like a room full of ten year olds that think they figured the world out but had a combined life experience of 1 month. Never dealt with that level of idiocy before and probably never will again.
Agree....another 3 posts to confirm.......
But as we know, the spin master had a new story because there’s no way he would ever admit he’s wrong about something.
Zimmer is looking to acquire Sintx to bolster sales in spine through LICENSING. Meaning Zimmer was looking to use Sintx Si3N4 for OEM purposes to supply other companies in spine
Strategic Alliances: Partnership among organizations working in pursuit of a common goal while maintaining organizational independence. This could mean aligning programs or administrative functions or adopting complementary strategies.
So I think, the underlying concern that we had with our portfolio was we haven't innovated since the acquisition of LDR, and we needed to continue to innovate the portfolio specifically to Mobi-C. So there's a couple of things we're doing there.
Representing approximately 40% of spine implants within the $10 billion global spine market, PEEK-based devices are favored because of their proven clinical efficacy. Through the development of 3DP SN-PEEK spinal implants, SINTX aims to combine the familiarity and benefits of PEEK with the antibacterial and osteoconductive characteristics of silicon nitride.
SINTX will collaborate with the University of Pennsylvania School of Veterinary Medicine (Penn Vet) over the next 24 months to execute this project. The NIH grant will support resourcing and acquisition of materials as well as testing and trials at SINTX and Penn Vet. Upon the successful execution of the Phase II grant application goals, SINTX will have the majority of the benchtop and large animal in vivo data needed to seek FDA regulatory clearance using the 510(k) pathway.
Lets look at the Spineblogger quote again because that quote seems to have provided Zimmers roadmap for its future more than anything else ive seen. Thanks for bringing up these old forum posts madg and CL as this particular quote contained information i didnt catch onto when i first found it! Its possible that Sintx stock has been tanked to try to distract from these points!
AnonymousMay 24, 2011 at 3:42 PM
Zimmer is looking at purchasing Amedica flat out for their techology to bolster sales in spine through licensing and to purchase the next generation of hip and knee implants. You heard it here on TSB.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
These are risk-averse companies that look to smaller companies like us to develop an idea, uh, and, uh, de-risk it, so to speak, and then buy that technology.
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Mr Bond, they have a saying in Chicago: 'Once is happenstance. Twice is coincidence. The third time it's enemy action'.
One is an incident, two is a coincidence, three's a pattern, and four is enough for a warrant
Yep, there was a post on cafepharma back in 2015 after the R&D agreement was signed May.
Word on the street is a merger/buyout with Amedica….any info or thoughts?
AnonymousMay 24, 2011 at 3:42 PM
Zimmer is looking at purchasing Amedica flat out for their techology to bolster sales in spine through licensing and to purchase the next generation of hip and knee implants. You heard it here on TSB.
These are risk-averse companies that look to smaller companies like us to develop an idea, uh, and, uh, de-risk it, so to speak, and then buy that technology.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Mr Bond, they have a saying in Chicago: 'Once is happenstance. Twice is coincidence. The third time it's enemy action'.
One is an incident, two is a coincidence, three's a pattern, and four is enough for a warrant
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Boston and CL literally used cafe pharma as part of their buyout thesis. Boston would always go “what about this post on cafe pharma saying zimmer was looking to acquire for America for spine? Nuff said” Imagine how hilarious it was once Sonny sold off spine. I could not stop laughing. But as we know, the spin master had a new story because there’s no way he would ever admit he’s wrong about something.
Lmao I’ll make sure to get right on that to ensure that I have shareholder participation rights for the big buyout reverse triangular merger!!!
Tone and Styling is what prompted me to say "Hello CL101".
How To Tell If Someone Is Controlled Opposition
What I can know is (A) what I’ve learned about the world, (B) the ways the political/media class is lying about what I know about the world, and (C) when someone says something which highlights those lies. I therefore pay attention solely to the message, and no attention to what may or may not be the hidden underlying agenda of the messenger.
In other words, if someone says something which disrupts establishment narratives, I help elevate what they’re saying in that specific instance. I do this not because I know that the speaker is legit and uncorrupted, but because their message in that moment is worthy of elevation. You can navigate the entire political/media landscape in this way.
Since society is made of narrative and power ultimately rests in the hands of those who are able to control those narratives, it makes no sense to fixate on individuals and it makes perfect sense to focus on narrative. What narratives are being pushed by those in power? How are those narratives being disrupted, undermined and debunked by things that are being said by dissident voices? This is the most effective lens through which to view the battle against the unelected power establishment which is crushing us all to death, not some childish fixation on who should or shouldn’t be our hero.
Sidetrack opponents with name calling and ridicule.
A form of an ad hominem attack, define the opponent with a label rather than inferior argumentation.
Proper response: Explain that such an approach implies “guilt by association and attack(s) truth on the basis of the messenger” (Sweeney).
Mr Bond, they have a saying in Chicago: 'Once is happenstance. Twice is coincidence. The third time it's enemy action'.
One is an incident, two is a coincidence, three's a pattern, and four is enough for a warrant
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Interesting stuff! Was completely unaware of cafepharma. Pretty amazing since this guy accused me of using various aliases, conspiracy role playing etc. And now he has you pegged as CL101 LOL. The only problem is I see that you and CL posted at concurrent times. Amazing that you and he weren't kicked off. Oh, that's right.....you and he weren't booted because....you're not the same individual. Oh, wait...maybe IHUB is part of the conspiracy! Someone needs to tell Mr. Know-it-all (delusionally speaking) that once again, he's the ONE caught in the lie. Oops, I just did.
Some more BS to distract from the obvious? How much are you getting paid from Sintx / MAXIM?
Hello CL101. Why do you think Zimmer was removed from Sintx 2013 IPO paperwork? Understand that if youre going to spread lies about me, try to intimidate me, then that'll just motivate me more to stick around. In fact those lies from 2018 are part of the reason im still here. For me to leave could be seen as tacit admission of guilt. Im not paid by anyone to post defend sintx, whatever. However I do not put it past someone like yourself to create accounts with my information, which you are obviously aware of, and put money into it. Thus i receive no payments im aware of. Max Link, Ph.D. has served as the Chairman of our board of directors since October 2003. Dr. Link served as Chairman of the Board and Chief Executive Officer of Centerpulse AG, the largest orthopedics company in Europe, from March 2002 until October 2003, when Centerpulse was acquired by Zimmer Holdings, Inc. Prior to joining Centerpulse, Max E. Link, Ph.D. has served as the chairman of our board of directors since October 2003. Dr. Link was chairman of the board of directors and Chief Executive Officer of Centerpulse AG, a medical implant company from March 2002 to October 2003. Prior to joining Centerpulse, Aaron A. Hofmann, M.D. is our co-founder and has been a member of our board of directors since 1996. Dr. Hofmann is a nationally and internationally recognized orthopedic surgeon, known for his accomplishments in developing total hip and knee replacement systems, innovative surgical approaches in hip and knee surgery and basic research on human bone dynamics. Dr. Hofmann holds 14 patents, many of which are directed at inventions involving hip and knee implants. Since 2003, Dr. Hofmann has been a design surgeon for Zimmer Holdings, Inc., the largest orthopedics company in the world. Dr. Hofmann, working with a team of orthopedic surgeons, helped design Zimmer’s new gender knee specifically designed for women. B. Sonny Bal, M.D. has served on our board of directors since February 2012. Dr. Bal is Professor & Chief of Adult Reconstruction at the University of Missouri, Columbia, specializing in hip and knee replacement surgery. He also is an Adjunct Professor of Material Sciences at the University of Missouri at Rolla. Dr. Bal is a member of the American Academy of Orthopaedic Surgeons and the American Association of Hip and Knee Surgeons. Dr. Bal received his M.D. degree from Cornell University and an M.B.A. from Northwestern University, and a J.D. from the University of Missouri. Dr. Bal is a licensed attorney and co-founder of the Bal Brenner law firm in North Carolina. Designer Surgeon Panel, Zimmer Inc., Warsaw, Indiana, 2002 to present.
Sintx ties to Zimmer were purposefully withheld from Sintx's IPO paperwork in 2013. Look at the summary about who Dr Link is for the 2007 IPO and compare that to the disclosure in the 2013 IPO paperwork. You will see that in the 2013 paperwork it was purposefully withheld that Zimmer acquired Centerpulse when Dr. Link was CEO of Centerpulse. Even how Centerpulse is described is vastly different between 2007/2013 paperwork.
Any investigation is unfortunately going to need to start right here as i suspect this is a breach of disclosure required. Most likely a small infraction. There is enough evidence to suggest intent.
Dr. Max Link, PHD (Chairman 2003-2014)
Next if you look at the summary of Dr Aaron Hofmann, cofounder of Sintx and a member of the board of Sintx when Sintx first tried to IPO, you'll see inclusion of him being a surgeon designer for Zimmer in the 2007 IPO paperwork. Yet the information about Dr Sonny Bal, also a board member, the fact that hes a surgeon designer for Zimmer in the 2013 IPO paperwork is not disclosed.
Disclosure about Dr. Hofmann, MD in 2007 IPO paperwork
Disclosure of Dr Bal, MD in the 2013 IPO paperwork:
We believe that Dr. Bal’s expertise in orthopedic surgery and his specialty in hip and knee replacement surgery qualifies him to serve on our board of directors
Per Dr Bals resume:
Total Joint Reconstruction Clinical Advisory Panel, Amedica Inc., Salt Lake City, UT, 2005 to present.
1. https://www.sec.gov/Archives/edgar/data/1269026/000119312507120692/ds1.htm pg 73
2. https://www.sec.gov/Archives/edgar/data/1269026/000119312513435409/d593074ds1.htm pg 89
3. https://www.sec.gov/Archives/edgar/data/1269026/000119312507120692/ds1.htm pg 74
4. https://www.sec.gov/Archives/edgar/data/1269026/000119312513435409/d593074ds1.htm pg 90
5. https://web.archive.org/web/20240316192627/https://hipandknee.com/wp-content/uploads/2014/04/Dr.-Bal-CV.pdf
Lets look at the full scope, im aware of, of Network Collaboration (Shared talent pool - Employees/Consultants) between Sintx and Zimmer, Biomet, & Zimmer Biomet starting with current CEO Dr. Sonny Bal.
Networks: People connected by relationships, which can take on a variety of forms, both formal and informal.
Designer Surgeon Panel, Zimmer Inc., Warsaw, Indiana, 2002 to present.
In addition, the trustees welcome to the board:
B. Sonny Bal, MD, JD, MBA (Columbia, MO); Paul C. Collins, MD (Boise, ID); David C. Dvorak, JD (Warsaw, IN)
Max Link, Ph.D. has served as the Chairman of our board of directors since October 2003. Dr. Link served as Chairman of the Board and Chief Executive Officer of Centerpulse AG, the largest orthopedics company in Europe, from March 2002 until October 2003, when Centerpulse was acquired by Zimmer Holdings, Inc.
Aaron A. Hofmann, M.D. is our co-founder and has been a member of our board of directors since 1996.
Since 2003, Dr. Hofmann has been a design surgeon for Zimmer Holdings, Inc.
The authors MA and JW receive research grants from Zimmer-Biomet, EIT and Intrinsics. MA and JW are consultants for Zimmer-Biomet and Silony and they receive royalties from EIT.
Dr. Saiz has worked as a Consultant for Zimmer Spine
Dr. Suh or an immediate family member has received royalties from Zimmer Biomet, is a member of a speakers’ bureau or has made paid presentations on behalf of Eli Lilly, and serves as a paid consultant to or is an employee of Amedica and Zimmer Biomet.
2015 Consulting revenue from LDR & Zimmer Biomet – $92,500
2014 Consulting revenue from LDR, Biomet, & Amedica – $107,000
Good advise:p
"Sintx pumper Scott Mosier whole point now is Zimmer won’t send a cease and desist his way because they are involved with Sintx as he says. SEC has been told by Dozens of investors of the constant pump and dump schemes, they don’t care as there is no money for them to take from sintx, they want money from actions they take, SEC 101. Send Zimmer attorneys this info that Scott Mosier spews daily about Zimmer and Sintx, one letter from them will shut this scam down. Sintx Investors so tired of being screwed they are coming for answers from so called stakeholders, per Scott Mosier that’s Zimmer. So no, we won’t go away, until Zimmer buys Sintx As we have been told they are for years now, or Zimmer makes Sintx pumpers quit saying their name daily to sell sintx shares.,"
Some years ago he spammed the Cafepharma and some other forums with the absolute same BS like he is doing here to lure in some new bagholders for Sonny. He also had a "blog" with some wild Amedica stories/predictions which never materialized for sure.
https://www.cafepharma.com/boards/threads/ctl-medical-buys-amedica-spine-scott-mosier-is-a-fraud.627450/
Oh, ok. Thanks for the info. Things were not adding up and I wondered why he took the proverbial "fifth amendment" during my recent inquiries. Makes sense....
It was already disclosed back in 2017 that Boston has a very close connection to the company and the CEO. madg and others are warning for several years now that Bostons agenda is not the one of retail ;)
For 100% he gets paid by writing the posts in favour of either Maxim or Sintx or both.
More love from Sonny....
This is their latest: PRE 14A
1. To approve an amendment to our amended and restated certification of incorporation to effect, at the discretion of our board of directors
(“Board”), a reverse stock split of all of our issued and outstanding shares of common stock at a ratio of not less than 1-for-100 and not greater
than 1-for-300, such ratio to be determined by our Board at any time within twelve months, without further approval or authorization of our stockholders;
Lets look at the full scope, im aware of, of Network Collaboration (Shared personnel resource pool - Employees/Consultants) between Sintx and Zimmer, Biomet, & Zimmer Biomet starting with current CEO Dr. Sonny Bal.
Networks: People connected by relationships, which can take on a variety of forms, both formal and informal.
Designer Surgeon Panel, Zimmer Inc., Warsaw, Indiana, 2002 to present.
In addition, the trustees welcome to the board:
B. Sonny Bal, MD, JD, MBA (Columbia, MO); Paul C. Collins, MD (Boise, ID); David C. Dvorak, JD (Warsaw, IN)
Max Link, Ph.D. has served as the Chairman of our board of directors since October 2003. Dr. Link served as Chairman of the Board and Chief Executive Officer of Centerpulse AG, the largest orthopedics company in Europe, from March 2002 until October 2003, when Centerpulse was acquired by Zimmer Holdings, Inc.
Aaron A. Hofmann, M.D. is our co-founder and has been a member of our board of directors since 1996.
Since 2003, Dr. Hofmann has been a design surgeon for Zimmer Holdings, Inc.
The authors MA and JW receive research grants from Zimmer-Biomet, EIT and Intrinsics. MA and JW are consultants for Zimmer-Biomet and Silony and they receive royalties from EIT.
Dr. Saiz has worked as a Consultant for Zimmer Spine
Dr. Suh or an immediate family member has received royalties from Zimmer Biomet, is a member of a speakers’ bureau or has made paid presentations on behalf of Eli Lilly, and serves as a paid consultant to or is an employee of Amedica and Zimmer Biomet.
2015 Consulting revenue from LDR & Zimmer Biomet – $92,500
2014 Consulting revenue from LDR, Biomet, & Amedica – $107,000
So Donald Bray who comes from Morgan Ceramics/NP Aerospace after Sintx and Morgan Ceramics partnership was disclosed 1.5 years before he joined. Just so happens to join Sintx to help obtain needed certifications for manufacturing, to help setup Sintx to produce Armor/Aerospace products, along with help Sintx acquire IP so Sintx could then supply NP Aerospace armor components it uses for its products according one of its patents. All of that, according to you, has nothing to do with Morgan Ceramics nor NP Aerospace? Just all one giant coincidence that Sintx can now sell aerospace products to Morgan Ceramics after Morgan Ceramics was using Sintx formulation for aerospace application. Just like its one giant coincidence that Sintx got into armor in the first place, as its been a medical company, and acquires equipment and license IP that it can then use to supply NP Aerospace. Then Bray leaves Sintx once armor is brought online as if he completed the tasks he was brought on for; remains on as a consultant. Wow its amazing that all that is not interconnected.
The above must not be examples of Network Collaborations or Strategic Alliance?
Networks: People connected by relationships, which can take on a variety of forms, both formal and informal.
Strategic Alliances: Partnership among organizations working in pursuit of a common goal while maintaining organizational independence. This could mean aligning programs or administrative functions or adopting complementary strategies.
Strategic Co-Funding: participating funders make a commitment to the same initiative or same set of grantees, but each separately donates money directly to the grantees to fund a portion of that initiative.
Together with a strategic partner, we have initiated biomechanical testing of our solid silicon nitride femoral heads. This testing is expected to continue through 2016. If the tests indicate that silicon nitride femoral heads are superior in terms of wear performance, taper corrosion, strength and in vitro hydrothermal stability, we eventually intend to commercialize this product in cooperation with a strategic partner.
Mr Bond, they have a saying in Chicago: 'Once is happenstance. Twice is coincidence. The third time it's enemy action'.
One is an incident, two is a coincidence, three's a pattern, and four is enough for a warrant
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Tell us how you really feel? LOL!!! Get ready. I can see the 18 disinfo flyer comin' your way.....Anyway, I think I'm totally done with this individual (I know, I know....I've said it before). Glad you did well on the J&J bit. May I suggest buying 100 shares of Sint to celebrate (and get voting rights to boot)? Haha....
No
No
No
For everyone’s amusement, the longer that this company stays public the better. Hopefully we get another 10 years to watch you keep putting all the clues together.
Meanwhile I got my buyout today from J&J. One of us knows what we are doing and the other gives a new meaning to mentally challenged
OK, so you can talk about NP Aerospace, good. Do you believe that Sintx has or had a partnership with NP Aerospace? Do you believe that NP Aerospace is a stakeholder in Sintx? Mr Bond, they have a saying in Chicago: 'Once is happenstance. Twice is coincidence. The third time it's enemy action'. One is an incident, two is a coincidence, three's a pattern, and four is enough for a warrant
Given the partnership Sintx has/had in place with Morgan Advanced Ceramics, do you believe that one of the aerospace supply agreements is to supply Morgan Advanced Ceramics or any of its subsidiaries?
In regards to the recent revelation of a co-funded study by Sintx and Biomet pertaining to use of both companies IP in testing, prior to 2007, do you agree that makes Biomet a stakeholder in Sintx?
BTW, i do not want a M&A event to happen with Np Aerospace.
========================================
Sintx - Morgan Ceramics partnership & NP Aerospace Connections
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174166246
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174166439
Sintx - Zimmer Connection
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174053353
Sintx - Zimmer connection purposefully not disclosed/removed from 2013 IPO paperwork?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174144294
Sintx - Biomet R&D
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174053136
Dr. Pezzotti member of Sintx scientific board and his research for Biomet
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174052660
Zimmer Biomet Hires Si3N4 Coatings Expert for its anti-infective dvision - December 2018
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174115529
Zimmer Biomet pays 2.5m certain R&D payment Q2 2017, Dr Bal's investment company loans $2.5m to Sintx.Q3, 2017
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174152867
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Stfu dude, I told your a$$ where this company was going back in ‘15-‘16. Now you want to cry wolf about manipulation this manipulation that like a little btch to excuse your ‘I’m smarter than everyone and I’m never wrong it’s just the world out to get me’. Fckin insane the amount of hubris you have with your dog sht track record. Don’t get me started with your attempts at analyzing a chart when you can’t trade to save your god dmn life but yet speak on chart technicals like you can.
Oh they increased revenue for one year after imploding revenue from $24mm to $500k and now they should be valued based on what? Sonny’s sht track record like yours? Went mum on weigao with zero fckin update so that you could speculate all day about it just like you’re doing with Morgan. Same sht all the time and you fall for it every god dmn time. The big contract that they just signed has no minimum purchase requirement. Let me guess it should be valued at the maximum amount because of what? Total contract is worth a max present value of what $5-6mm and that’s their own internal maximum revenue projections over the life of the contract.
Keep buying more dude that NP buyout right around the corner. Once that doesn’t happen you can find the next carrot to incinerate your family’s resources on and try to pull someone else down with you on this board for the millionth time.
Helping him? Lol, how...by calling him (them) out for being crooks, inept, greedy? Obviously, NONE of them have EVER been for shareholders. And people like yourself, have only helped shareholders lose MORE money (provided they were foolish enough to listen to you). Good job! Normally, I'd feel sorry for someone getting decimated, but in your case it's difficult to, considering all the posts you deleted etc in order to get ONLY your view across; not to mention all the accusations, innuendos etc you threw (and continue to throw) at those who oppose your wacky views.
Btw, you never did answer how you could be unaware ("to my knowledge") if you were being compensated or not. Doesn't seem too difficult a job to figure out.
This study seems to have been funded by Sintx, then Amedica, and Biomet before it merged with Zimmer in 2007
So now you're saying Sonny's a crook?
Mr Bond, they have a saying in Chicago: 'Once is happenstance. Twice is coincidence. The third time it's enemy action'.
One is an incident, two is a coincidence, three's a pattern, and four is enough for a warrant
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
So now you're saying Sonny's a crook?
Someone is trying to steal this tech and that can only happen with management being onboard.
Looking at this chart again, its hard to see that the reason for the excessive drops were a combination of 50% drops in price between first filing of offering and the actual offering price and 50% drops post offering.
https://i.imgur.com/xMRDE8n.jpeg
Turns out since the announcement of the rights offering in 2022, the stock has dropped 50% between announcement of offering and the actual offering. Then after the offering the stock took another 50% haircut.
July 8th, stockprice was .47. Sept 26 the offering began and immediately the price dropped from .40s to .20 cents. No news to justify the drop.
Offering price .15
Drops to 6 cents post offering before RS.
February offering was extremely odd one. Offering filed at a price of 8.61, the price jumped to as high as 12 (likely loading of naked shorts). Then for reasons i dont understand the offering was priced at 5.6 despite closing at 7.6 the day before. Post offering the stock halved within two days.
Then after the stock kept bleeding over the next several months before the S-3 was filed Oct 12th at a price of .77. Price bled to .60 when the S-1 was filed. Offering price would be .25 despite news of 1 of 2 aerospace contracts and the fact company doubled its revenue for 2023. It should double again in 2024 with selling of spine blanks and ~up to 1m in aero revenue. After offering the stock halved where it sat until suddenly there was an offering at 4.7 cents again for no reason. Halved again post offering with another offering at 2.1 cents.
This has got to be the hallmarks of price manipulation and i was warned to sell before this drop indicating this was planned beforehand. Of course i saw no reason for the drop and every reason to hold so i did. There has been nothing to justify the drops. The company's position continues to improve. The tech that Sonny so aggressively patents, worth well over $225m, seems to be worthless according to the markets. This despite stakeholders in Zimmer Biomet, Morgan Ceramics, and former Morgan Ceramic subsidiary NP Aerospace, and despite the fact that the IP could one day replace current ortho materials. It looks like someone is trying to steal this tech and that can only happen with management being onboard.
This study seems to have been funded by Sintx, then Amedica, and Biomet before it merged with Zimmer in 2007. All evidence of this hip implant developed by Sintx to date indicate a Sintx femoral head, Biomet liner (E1 now over Arcom), Si3n4 coating of a Biomet G7 Acetabular Shell. Thus Biomet is a stakeholder in Sintx and now Zimmer Biomet. More on this in the following posts.
Acknowledgements The authors thank Amedica, Utah, US and Biomet Inc, US for their support
Mr Bond, they have a saying in Chicago: 'Once is happenstance. Twice is coincidence. The third time it's enemy action'.
One is an incident, two is a coincidence, three's a pattern, and four is enough for a warrant
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
The following chart that i copied was posted by Taman78 who seems to have deleted the account? The area in the yellow is where the trend should have started to recover as Sintx revenue began increasing. However as you can see, instead of beginning to recover, it began dropping with impunity. There has been no news of anything to justify this level of dropping and is why shares are being flooded into the markets as we speak. Obviously Sintx also needed to raise funds. However theres been extensive naked shorting of the stock as shown by fail to delivers. Wait until the FTDs are published for the current flood of shares in a month. Mr Bond, they have a saying in Chicago: 'Once is happenstance. Twice is coincidence. The third time it's enemy action'. One is an incident, two is a coincidence, three's a pattern, and four is enough for a warrant
20240201|829392604|SINT|696466|SINTX TECHNOLOGIES INC COM COM|0.15
20240202|829392604|SINT|5939951|SINTX TECHNOLOGIES INC COM COM|0.15
20240205|829392604|SINT|113856|SINTX TECHNOLOGIES INC COM COM|0.16
20240223|829392604|SINT|331948|SINTX TECHNOLOGIES INC COM COM|0.14
https://www.sec.gov/data/foiadocsfailsdatahtm
One of the accounts bashing Sintx on ST was TAman78 and it seems this person deleted their account. This implies guilt unless ST just glitched. They were definitely guilty of repeated lies intermixed with a degree of truth.
https://stocktwits.com/TAman78
========================================
Sintx - Morgan Ceramics partnership & NP Aerospace Connections
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174166246
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174166439
Sintx - Zimmer Connection
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174053353
Sintx - Zimmer connection purposefully not disclosed/removed from 2013 IPO paperwork?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174144294
Sintx - Biomet R&D
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174053136
Dr. Pezzotti member of Sintx scientific board and his research for Biomet
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174052660
Zimmer Biomet Hires Si3N4 Coatings Expert for its anti-infective dvision - December 2018
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174115529
Zimmer Biomet pays 2.5m certain R&D payment Q2 2017, Dr Bal's investment company loans $2.5m to Sintx.Q3, 2017
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174152867
One particular scenario im concerned with is some sort of merger with NP Aerospace. There is some synergistic value there as NP has OEM products in the medical, energy, & transportation markets in addition to armor and aerospace i believe. Obviously Sintx has products/product candidates in each of these markets and a shared resource in Mr Donald Bray who oversaw NP Aerospace subsidiaries at Morgan Ceramics before joining Sintx and setting up armor/defense/aerospace. Mr Bond, they have a saying in Chicago: 'Once is happenstance. Twice is coincidence. The third time it's enemy action'. One is an incident, two is a coincidence, three's a pattern, and four is enough for a warrant
The way Sint stock is trading and the massive influx of shares flooding the market, this could potentially be used to create the context for shareholders of Sintx to vote for said merger; of course all shareholders have been scared away so whatever parties holding all these new shares would likely be positioned to vote for said merger. The context being created is years worth of attacking management showcasing incompetence, lack of bringing several products to market just sitting on them like Masks, to financial distress as Sintx would have little option but to accept such a merger if it cant raise sufficient funds to continue to fund its operations. Sintx funds its R&D efforts mostly primarily through the public markets. Thus keeping Sintx valuation ultra low and making it more and more difficult for Sintx to fund itself, is a great way to force such a transaction. Just look at the chart in 2022 when the trend violently departed from the general downtrend to the massive drop since despite all the good news the company has released. Me, without more information, id rather see Sintx auction its IP than merge with NP Aerospace or any other entity other than Zimmer Biomet or maybe Morgan Ceramics.
As i said previously, if this is indeed how things are going to play out, Zimmer Biomet will become a more predominate figure after said transaction. How quickly i couldnt say. Zimmer Biomet is a stakeholder in Sintx as i show with extensive evidence. So if it wanted to stop this it could by simply announcing an official collaboration/partnership/whatever with Sintx on at minimum a hip implant that has already been developed with both companies IP. If Zimmer Biomet stays silent then it wants this; Zimmer Biomet is looking to diversify its product portfolio i just do not know to what extent. Zimmer Biomet will use Sintx for its strategic benefit the way Eli Lilly used Amylin. Evidence suggests that Eli "traded" Amylin to Bristol Myers in a behind the scenes deal that lead to Eli acquiring Bristol Myers partner Imclone and Bristol acquiring Eli partner Amylin 4 years later. Thus showcasing these sorts of deals do not always have a straight path.
========================================
Sintx - Morgan Ceramics partnership & NP Aerospace Connections
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174166246
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174166439
Sintx - Zimmer Connection
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174053353
Sintx - Zimmer connection purposefully not disclosed/removed from 2013 IPO paperwork?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174144294
Sintx - Biomet R&D
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174053136
Dr. Pezzotti member of Sintx scientific board and his research for Biomet
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174052660
Zimmer Biomet Hires Si3N4 Coatings Expert for its anti-infective dvision - December 2018
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174115529
Zimmer Biomet pays 2.5m certain R&D payment Q2 2017, Dr Bal's investment company loans $2.5m to Sintx.Q3, 2017
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174152867
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
OK, so you can talk about NP Aerospace, good. Do you believe that Sintx has or had a partnership with NP Aerospace? Do you believe that NP Aerospace is a stakeholder in Sintx? Mr Bond, they have a saying in Chicago: 'Once is happenstance. Twice is coincidence. The third time it's enemy action'. One is an incident, two is a coincidence, three's a pattern, and four is enough for a warrant
Given the partnership Sintx has/had in place with Morgan Advanced Ceramics, do you believe that one of the aerospace supply agreements is to supply Morgan Advanced Ceramics or any of its subsidiaries?
In regards to the recent revelation of a co-funded study by Sintx and Biomet pertaining to use of both companies IP in testing, prior to 2007, do you agree that makes Biomet a stakeholder in Sintx?
========================================
Sintx - Morgan Ceramics partnership & NP Aerospace Connections
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174166246
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174166439
Sintx-Zimmer Connection
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174053353
Sintx - Zimmer connection purposefully not disclosed/removed from 2013 IPO paperwork?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174144294
Sintx-Biomet R&D
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174053136
Dr. Pezzotti member of Sintx scientific board and his research for Biomet
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174052660
Zimmer Biomet Hires Si3N4 Coatings Expert
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174115529
Zimmer Biomet pays 2.5m certain R&D payment Q2 2017, Sonny loans $2.5m to Sintx.Q3, 2017
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174152867
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Followers
|
240
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
41288
|
Created
|
02/13/14
|
Type
|
Free
|
Moderators Atlanta1 Tesla thru the roof |
https://www.youtube.com/watch?v=j94SgeyCh3M
(AMDA) Amedica Corp. - NASDAQ
RECENT NEWS
https://www.youtube.com/watch?v=hxbj7Sq7W94
https://www.youtube.com/watch?v=j94SgeyCh3M
https://www.youtube.com/watch?v=KbU47COpXx8
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |